Zealthy is a telehealth platform founded in 2023 that prescribes GLP-1 receptor agonists for weight loss to eligible adults across all 50 US states. The platform operates fully online, combining clinical evaluation with insurance navigation support.
Zealthy uses FDA-approved GLP-1 medications and offers compounded alternatives starting at $151 per month. Its Insurance Concierge service reduces brand-name GLP-1 costs to as low as $25 per month for insured patients. Independent reviewers named it ‘best digital weight loss program overall’ for affordability and support.
App store reviews flag communication and portal issues that contrast with the platform’s clinical strengths. This review covers Zealthy’s medications, pricing, safety, and whether it delivers on its weight loss promises.
What Is Zealthy Weight Loss?
Zealthy is a telehealth platform founded in early 2023 that delivers weight loss programs through GLP-1 medications and personalized clinical support. The platform operates fully online, connecting patients with licensed medical providers across weight loss, mental health, and primary care categories. Zealthy’s digital-first model removes geographic barriers, making medical-grade weight loss accessible nationwide.
Zealthy’s core mission centers on affordability and patient-centered care. The platform integrates clinical evaluation, insurance navigation, and ongoing support into a single digital experience. This combination distinguishes Zealthy from traditional telehealth services that offer only prescriptions without care coordination.
The Zealthy weight loss program differentiates itself by lowering barriers to GLP-1 treatment. Most platforms leave patients to navigate insurance alone. Zealthy’s proprietary Insurance Concierge service handles prior authorizations and coverage questions directly, reducing the complexity patients face when accessing brand-name medications.
How Does Zealthy’s Program Work?
Zealthy’s program begins with an online intake where affiliated licensed medical providers evaluate a patient’s health history, goals, and clinical profile before determining the appropriate treatment plan. Patients complete this intake entirely through the platform’s digital interface without an in-person visit. Providers then build a personalized care plan based on individual eligibility.
Once enrolled, patients receive access to a full suite of support services. The care journey includes medication fulfillment, Insurance Concierge support for prior authorizations, and direct access to weight loss coaches and care coordinators. Each element of the journey runs through the same integrated platform.
Who Is Zealthy Designed For?
Zealthy serves adults seeking GLP-1-based weight loss treatment who want affordable access to clinical care with or without insurance coverage. The platform assesses each patient on a case-by-case basis to determine clinical eligibility. Patients must qualify through the online intake to access prescription-based treatment options.
Beyond weight loss, Zealthy extends its model to patients seeking mental health care, birth control, ED treatment, skincare, and hair loss services. The platform’s nationwide reach means eligible patients in all 50 states can access the same standard of care. This breadth makes Zealthy a comprehensive digital health provider, not only a weight loss platform.
What Medications Does Zealthy Prescribe?
Zealthy primarily prescribes GLP-1 receptor agonists — a class of medications originally developed for type 2 diabetes and now FDA-approved for treating obesity in eligible adults. These drugs work by regulating blood glucose and suppressing appetite, and are typically self-administered by subcutaneous injection. The platform prescribes both brand-name and compounded versions depending on insurance coverage and clinical eligibility.
Brand-name GLP-1 options are available through Zealthy’s Insurance Concierge for patients with qualifying coverage, often reducing the monthly cost significantly below retail pricing. For patients without insurance or without coverage for these drugs, Zealthy offers compounded GLP-1 alternatives through its cash-pay pathway starting at $151 (approximately €140) per month.
Compounded GLP-1 drugs use the same active ingredients as brand-name versions but do not carry individual FDA approval. Zealthy prescribes these subject to clinical eligibility and applicable prescribing requirements, giving patients access to semaglutide-based treatment even when brand-name options are inaccessible.
Does Zealthy Use GLP-1 Medications?
Yes. Zealthy uses GLP-1 receptor agonists as its primary weight loss medications, leveraging the same drug class FDA-approved for obesity treatment in clinical practice. GLP-1 medications regulate glucose levels, reduce appetite, and slow gastric emptying — mechanisms that together reduce caloric intake and support sustained weight loss. Patients self-administer these medications by subcutaneous injection, typically weekly.
Zealthy expanded its GLP-1 program nationwide in April 2026, increasing access to both brand-name and compounded GLP-1 medications for eligible patients across all 50 US states. This expansion reflects growing demand for telehealth-based GLP-1 prescribing and Zealthy’s investment in scaling its clinical infrastructure.
Is Compounded Semaglutide Available Through Zealthy?
Yes. Zealthy offers compounded GLP-1 alternatives including semaglutide-based compounded medications as cash-pay options for patients whose insurance does not cover brand-name GLP-1 drugs. These compounded options use the same active ingredient as brand-name versions like Ozempic and Wegovy but are manufactured without individual FDA approval. Clinical eligibility is required before any prescription is issued.
The cash-pay cost for compounded GLP-1s through Zealthy starts at $151 (approximately €140) per month. This pricing makes GLP-1-based weight loss accessible to patients who lack coverage and cannot afford brand-name retail prices, which often exceed $1,000 (approximately €920) per month without insurance.
What Are the Benefits of Zealthy Weight Loss?
Zealthy excels in three areas that patients consistently cite as barriers to effective weight loss care: affordability, convenience, and ongoing clinical support throughout the treatment journey. The platform accepts insurance for brand-name GLP-1 medications and offers cash-pay compounded alternatives, ensuring two distinct price points for different patient situations. Subscribers also gain continuous access to expert providers and a dedicated care coordination team.
The Insurance Concierge service is Zealthy’s most distinctive feature. A dedicated team handles all insurance navigation, prior authorizations, and coverage questions on the patient’s behalf. This service targets one of the most common reasons patients abandon GLP-1 treatment — the complexity and time cost of insurance interactions.
Subscribers receive remote access to expert providers, weight loss coaches, and care coordinators throughout their program. This ongoing support layer differentiates Zealthy from platforms that offer prescriptions alone. The care coordination team works directly with patients’ insurance companies to secure medication coverage, reducing out-of-pocket costs over time.
Key Program Benefits:
- Brand-name GLP-1 access for as little as $25/month with qualifying insurance
- Compounded GLP-1 options from $151/month for cash-pay patients
- Insurance Concierge handles prior authorizations and coverage navigation
- Remote access to licensed providers, weight loss coaches, and care coordinators
- Integrated platform covering clinical evaluation, medication fulfillment, and ongoing support
Does Zealthy Actually Help You Lose Weight?
Yes. Zealthy leverages FDA-approved GLP-1 receptor agonists with clinically proven efficacy for weight loss in eligible adults, the same medications studied extensively in obesity clinical trials. GLP-1 drugs reduce body weight by suppressing appetite and reducing caloric intake — a mechanism validated in multiple large-scale clinical studies. The medications Zealthy prescribes are not experimental; they are the same compounds used in mainstream obesity medicine.
Independent reviewers awarded Zealthy the endorsement of ‘best digital weight loss program overall’ for its combination of affordable compounded medications and personalized care coordination. This recognition reflects the platform’s integration of clinical-grade medications with the support infrastructure needed for sustained results.
Does Zealthy Offer Ongoing Medical Support?
Yes. Zealthy provides continuous remote access to expert medical providers, weight loss coaches, and care coordinators throughout the entire treatment journey — not only at initial prescription. This ongoing support model ensures patients have clinical guidance available as their treatment evolves. Providers can adjust treatment plans based on patient response and changing health circumstances.
The platform combines clinical evaluation, insurance support, transparent entry pricing, and medication fulfillment into one integrated experience. Patients do not need to manage multiple providers or platforms. Zealthy’s single-platform approach reduces friction and keeps the care team accessible at every stage of the weight loss program.
What Do Zealthy Reviews Say?
Zealthy reviews reveal a split profile: independent professional reviewers endorse the platform as the best overall digital weight loss program, while app store user reviews flag operational and communication issues. The contrast reflects a common pattern among telehealth platforms — clinical and pricing strengths that outperform peers, alongside customer service execution gaps that affect user experience. Both perspectives are present in publicly available review data.
App store reviews reference recurring complaints about communication problems and portal organization. Review titles include ‘not as seamless as you’d think,’ ‘poor company organization,’ and ‘serious communication issues.’ These reviews suggest the platform’s backend operations and customer-facing communication systems need improvement relative to its clinical offering.
What Do Positive Zealthy Users Report?
Positive Zealthy users consistently highlight the platform’s fast and simple intake process, affordable medication access through insurance, and convenience of remote provider interactions as the strongest aspects of the experience. Patients with qualifying insurance report accessing brand-name GLP-1 medications for as little as $25 (approximately €23) per month — a fraction of retail pricing that makes sustained treatment economically viable.
Users who successfully navigated the Insurance Concierge process report significant savings on brand-name GLP-1 prescriptions. The convenience of remote appointments and digital prescription management also receives consistent praise, particularly among patients who previously faced barriers accessing in-person weight loss care.
What Are the Common Complaints About Zealthy?
The most common Zealthy complaints center on communication breakdowns and platform organization issues, with app store reviewers citing poor company organization and serious communication problems as recurring themes. These complaints point to gaps between Zealthy’s clinical strengths and its customer service execution. Patients report difficulty navigating the patient portal and inconsistent responses from the care coordination team.
Customer service and portal navigation issues appear consistently across negative reviews. These pain points are operationally distinct from the platform’s clinical offering — the medications and clinical protocols receive fewer complaints than the administrative and communication experience. Patients considering Zealthy should set expectations around response time and portal usability.
How Much Does Zealthy Cost?
Zealthy costs vary by insurance coverage status: brand-name GLP-1 medications cost as little as $25 (approximately €23) per month with qualifying insurance, while compounded GLP-1 alternatives start at $151 (approximately €140) per month for cash-pay patients. The Insurance Concierge service works to secure the lowest possible out-of-pocket cost for patients with coverage. This dual pricing structure makes Zealthy accessible across a wider income range than many competitors.
The $25/month insurance pathway represents a significant discount from brand-name GLP-1 retail pricing, which regularly exceeds $1,000 (approximately €920) per month without coverage. Zealthy’s Insurance Concierge handles the prior authorization and coverage negotiation required to reach this pricing tier, a service most telehealth competitors do not offer.
Transparent entry pricing is a stated priority for the platform. Zealthy integrates clinical evaluation, insurance support, and medication fulfillment costs into a single transparent cost structure. Patients begin with an online intake that clarifies pricing options before committing to any plan.
Zealthy Pricing Overview:
| Pathway | Medication Type | Starting Monthly Cost |
|---|---|---|
| Insurance (with qualifying coverage) | Brand-name GLP-1 | $25 (~€23) |
| Cash-pay | Compounded GLP-1 | $151 (~€140) |
| Self-pay (without insurance navigation) | Brand-name GLP-1 (retail) | $1,000+ (~€920+) |
Is Zealthy Worth the Price?
Zealthy delivers strong value relative to competitors by combining Insurance Concierge support with GLP-1 prescribing — a combination that reduces out-of-pocket medication costs significantly below what most telehealth platforms charge. Independent reviewers named Zealthy ‘best digital weight loss program overall’ for this exact combination of affordability, convenience, and holistic ongoing support. The value case is strongest for patients who qualify for insurance-subsidized brand-name GLP-1 access.
Compared to Hers and other telehealth weight loss platforms, Zealthy competes favorably on cost and breadth of support services. Hers offers more treatment variety, but Zealthy’s Insurance Concierge gives it a cost advantage that matters most for long-term program adherence. Patients who need medication affordability over treatment variety will find Zealthy the stronger option.
Is Zealthy Legit and Safe?
Zealthy is a legitimate nationwide telehealth provider operating with affiliated licensed medical providers across all 50 US states, with a clinical model built on FDA-approved medications and licensed medical oversight. The platform is not a supplement company or a subscription wellness service — it is a regulated telehealth business operating under applicable healthcare and prescribing laws. All treatment plans are determined by licensed providers on a case-by-case basis.
Medical oversight runs throughout the patient journey, not only at the initial consultation. Licensed providers determine treatment eligibility, set the appropriate medication type and dosage, and monitor patient progress remotely. This clinical structure provides a safety framework that distinguishes Zealthy from non-medical weight loss programs.
GLP-1 medications prescribed through Zealthy have established safety profiles validated in FDA clinical trials for obesity treatment. Compounded GLP-1 alternatives use the same active ingredients as brand-name versions. Patients should discuss individual risk factors with their Zealthy provider before beginning any GLP-1-based treatment.
Is Zealthy FDA Approved?
No. Zealthy as a telehealth platform is not subject to FDA approval — the FDA approves drugs and medical devices, not healthcare delivery platforms. However, the brand-name GLP-1 medications Zealthy prescribes carry FDA approval for obesity treatment. Compounded GLP-1 alternatives use the same active ingredients but are not individually FDA-approved, as compounded medications are regulated differently from brand-name drugs.
Patients seeking brand-name FDA-approved GLP-1 medications like Ozempic or Wegovy can access these through Zealthy’s Insurance Concierge pathway. Patients on the compounded pathway should understand that these medications have the same active ingredient but operate under a different regulatory framework. Zealthy’s providers are equipped to explain these distinctions during the intake process.
Where Can You Buy Zealthy?
Zealthy is accessible exclusively through its digital platform — patients initiate care by checking eligibility and viewing personalized treatment options through GetZealthy.com, the platform’s primary access point. There is no physical storefront or pharmacy to visit. The entire journey from intake to medication fulfillment operates through the platform’s online interface and delivery network.
Following its April 2026 nationwide expansion, Zealthy is available to eligible patients across all 50 US states. Both the insurance pathway and the cash-pay pathway are accessible regardless of location, provided patients meet clinical eligibility criteria. Medication fulfillment is handled through Zealthy’s delivery infrastructure and arrives directly to the patient’s address.
Should You Try Eat Proteins for Weight Loss Support?
Eat Proteins provides protein-focused nutritional strategies that complement medical weight loss programs like Zealthy, helping patients preserve muscle mass and sustain results during GLP-1 treatment. Clinical evidence confirms that adequate protein intake supports muscle retention during caloric deficit — a critical factor when GLP-1 medications drive rapid weight loss. Neglecting protein during GLP-1 treatment risks losing lean mass alongside fat.
Our team at Eat Proteins works with patients pursuing medical weight loss by addressing dietary habits alongside their prescribed medication regimen. GLP-1 medications reduce overall appetite, which can inadvertently reduce protein intake if patients do not intentionally prioritize it. Eat Proteins’ guidance ensures patients meet protein targets even as their total caloric intake decreases.
For anyone considering or currently using Zealthy’s program, the Eat Proteins approach adds a nutrition layer that Zealthy’s clinical model does not directly address. You are not choosing between Zealthy and Eat Proteins. You are adding nutritional accountability to an already evidence-based medical treatment. That combination produces better outcomes than medication alone.